Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
US Department of Justice
McKesson
Chinese Patent Office
Farmers Insurance
Express Scripts
Merck
Queensland Health
Federal Trade Commission
Cerilliant

Generated: August 19, 2017

DrugPatentWatch Database Preview

Felodipine - Generic Drug Details

« Back to Dashboard

What are the generic sources for felodipine and what is the scope of felodipine patent protection?

Felodipine
is the generic ingredient in two branded drugs marketed by Sun Pharm Inds Ltd, Vintage Pharms Llc, Aurobindo Pharma Ltd, Orchid Hlthcare, Astrazeneca, Mylan, Heritage Pharms Inc, Glenmark Generics, Torrent Pharms Ltd, Jubilant Generics, Wockhardt Ltd, and Sun Pharm Inds, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for felodipine. Twenty-one suppliers are listed for this compound.

Summary for Generic Name: felodipine

Tradenames:2
Patents:0
Applicants:12
NDAs:12
Drug Master File Entries: see list17
Suppliers / Packagers: see list21
Bulk Api Vendors: see list91
Clinical Trials: see list15
Patent Applications: see list7,595
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:felodipine at DailyMed

Pharmacology for Ingredient: felodipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Generics
FELODIPINE
felodipine
TABLET, EXTENDED RELEASE;ORAL203983-001Aug 19, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Generics
FELODIPINE
felodipine
TABLET, EXTENDED RELEASE;ORAL090365-001Dec 17, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Orchid Hlthcare
FELODIPINE
felodipine
TABLET, EXTENDED RELEASE;ORAL203032-002May 21, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Astrazeneca
PLENDIL
felodipine
TABLET, EXTENDED RELEASE;ORAL019834-004Sep 22, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Wockhardt Ltd
FELODIPINE
felodipine
TABLET, EXTENDED RELEASE;ORAL091484-002Aug 15, 2012DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: felodipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
PLENDIL
felodipine
TABLET, EXTENDED RELEASE;ORAL019834-002Jul 25, 1991► Subscribe► Subscribe
Astrazeneca
PLENDIL
felodipine
TABLET, EXTENDED RELEASE;ORAL019834-004Sep 22, 1994► Subscribe► Subscribe
Astrazeneca
PLENDIL
felodipine
TABLET, EXTENDED RELEASE;ORAL019834-001Jul 25, 1991► Subscribe► Subscribe
Astrazeneca
PLENDIL
felodipine
TABLET, EXTENDED RELEASE;ORAL019834-004Sep 22, 1994► Subscribe► Subscribe
Astrazeneca
PLENDIL
felodipine
TABLET, EXTENDED RELEASE;ORAL019834-001Jul 25, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Dow
Citi
Chubb
Medtronic
Colorcon
Fish and Richardson
Harvard Business School
McKesson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot